Immunodeficiency and lymphocyte ecto-5′-nucleotidase activity in the elderly: A comparison of the effect of a trace mineral supplement (1 USRDA) with high zinc (6.7 X USRDA)

Methods of Assessment of Zinc Status in Humans: An Updated Review and Meta-analysis

CONTEXT

The assessment of zinc status is difficult but essential for the identification of zinc deficiency and evaluation of interventions to improve zinc status.

OBJECTIVE

The purpose of this systematic review (SR) and meta-analysis was to update the previously published SR of biomarkers of zinc status, conducted by the European Micronutrient Recommendations Aligned (EURRECA) network in 2009, to answer the question: Which putative measures (biomarkers) of zinc status appropriately reflect a change in zinc intake of at least 2 weeks?

DATA SOURCES

A structured search strategy was used to identify articles published between January 2007 and September 2022 from MEDLINE (Ovid), Embase (Ovid), Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials (CENTRAL). Relevant articles were identified using previously defined eligibility criteria.

DATA EXTRACTION

Data were extracted and combined with data from the previous SR.

DATA ANALYSIS

A random-effects model was used to calculate pooled mean differences using STATA (StataCorp). The risk of bias and the certainty of evidence for all outcomes were assessed. Additional data on 7 of the 32 previously reported biomarkers were identified, along with data on an additional 40 putative biomarkers from studies published since 2007. Pooled data analysis confirmed that, in healthy participants, both plasma/serum zinc concentration and urinary zinc excretion responded to changes in zinc intake (plasma/serum: mean effect [95% CI], controlled studies: 2.17 µmol/L [1.73, 2.61]; P < .005, I2 = 97.8; before-and-after studies: 2.87 µmol/L [2.45, 3.30]; P < .005, I2 = 98.1%; urine zinc: 0.39 mmol/mol creatinine [0.17, 0.62]; P < .005, I2 = 81.2; 3.09 µmol/day [0.16, 6.02]; P = .039, I2 = 94.3).

CONCLUSION

The updated analyses support the conclusion that plasma/serum and urinary zinc respond to changes in zinc intake in studies of healthy participants. Several additional putative biomarkers were identified, but more studies are needed to assess the sensitivity and reliability.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO no. CRD42020219843.

Methods of assessment of zinc status in humans: a systematic review

BACKGROUND

Zinc is an essential micronutrient for human health and has numerous structural and biochemical roles. The search for a reliable, sensitive, and specific index of zinc status has been the subject of considerable research, which has resulted in the identification of a number of potentially useful biomarkers.

OBJECTIVE

The objective was to assess the usefulness of biomarkers of zinc status in humans.

DESIGN

The methods included a structured search strategy using Ovid MEDLINE, EMBASE (Ovid), and the Cochrane Library CENTRAL databases; formal inclusion and exclusion criteria; data extraction into an Access database; quality and validity assessment; and meta-analysis.

RESULTS

Data on 32 potential biomarkers from 46 publications were analyzed. Plasma zinc concentration responded in a dose-dependent manner to dietary manipulation in adults, women, men, pregnant and lactating women, the elderly, and those at low and moderate baseline zinc status. Urinary zinc excretion responded to zinc status overall and in all subgroups for which there were sufficient data. Hair zinc concentration also responded, but there were insufficient studies for subgroup analysis. Platelet, polymorphonuclear cell, mononuclear cell, and erythrocyte zinc concentration and alkaline phosphatase activity did not appear to be effective biomarkers of zinc status.

CONCLUSIONS

This systematic review confirms that in healthy individuals, plasma, urinary, and hair zinc are reliable biomarkers of zinc status. Further high-quality studies using these biomarkers are required, particularly in infants, adolescents, and immigrant population groups for whom there are limited data. Studies are also required to fully assess a range of additional potential zinc biomarkers.

Immunosenescence and infectious diseases

Infectious diseases are major causes, with malignancies, of morbidity and mortality in the elderly. Increased susceptibility to infections may result from underlying dysfunction of an aged immune system; moreover, inappropriate immunologic functions associated with aging can determine an insufficient response to vaccines. Impairments of cellular, humoral and innate immunity in the elderly, contributing to increased incidence of infectious diseases, are discussed in this review.

Cytogenetic effects of copper-containing intrauterine contraceptive device (IUCD) on blood lymphocytes

Forty women using the copper-containing intrauterine contraceptive device (IUCD) for various periods and 22 control women were studied. The copper and zinc levels were measured in the plasma of the IUCD users and the control group. Chromosomal analyses were performed on blood lymphocytes of the same groups. Results showed that plasma copper level was significantly higher in the IUCD users than in that of controls (1.25+/-0.14 microg/ml vs. 0.89+/-0.04 microg/ml, P<0. 05). A decline in plasma zinc level from 2.90+/-0.41 microg/ml to 1. 27+/-0.13 microg/ml, P<0.05, with a significant alteration in plasma copper/zinc ratio was also measured in the IUCD women (62% vs. 111%, P<0.05). Chromosomal aberrations (4.47+/-1.40 vs. 0.62+/-0.12/100 cell, P<0.01) and high frequencies of sister chromatid exchanges (8. 79+/-0.46 vs. 6.59+/-0.19 SCE/cell, P<0.01) were evident in the IUCD women especially in those using the IUCD for more than 24 months. The combination of high copper plasma level, chromosomal aberrations and the increased frequency of sister chromatid exchange may support the existence of a positive correlation between the long term use of the IUCDs and DNA damage in the host somatic cells.